• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

过氧化物酶体增殖物激活受体α的激活可改善乙醇诱导的小鼠肝纤维化。

Activation of peroxisome proliferator activated receptor alpha ameliorates ethanol mediated liver fibrosis in mice.

机构信息

Department of Traditional and Western Medical Hepatology, Third Hospital of Hebei Medical University, Shijiazhuang, China.

出版信息

Lipids Health Dis. 2013 Feb 6;12:11. doi: 10.1186/1476-511X-12-11.

DOI:10.1186/1476-511X-12-11
PMID:23388073
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3608939/
Abstract

BACKGROUND

Peroxisome proliferator activated receptor alpha (PPARα) ameliorates ethanol induced hepatic steatohepatitis. However, its role in alcoholic liver fibrosis has not been fully clarified. The aim of this study was to elucidate the effect and the molecular basis of PPARα in ethanol induced liver fibrosis in mice.

METHODS

C57BL/6J mice were fed with 4% ethanol-containing Lieber-DeCarli liquid diet for eight weeks, and intraperitoneal injected with 5% carbon tetrachloride (CCl4) for the last four weeks to induce alcoholic liver fibrosis. PPARα agonist WY14643 was administered to mice during the last couple of weeks. The effects of PPARα induction on liver histology, activation of hepatic stellate cells (HSCs), as well as hepatic expression of inflammatory and fibrogenic factors were assessed.

RESULTS

The ethanol plus CCl4 treated mice exhibited progressive liver injury including piecemeal necrosis of hepatocytes, severe inflammatory cells infiltration and bridging fibrosis. This was accompanied by down-regulated hepatic expression of PPARα and the protective cytokines adiponectin, heme oxygenase-1 and interleukin-10. Additionally, up-regulation of the proinflammatory cytokine tumor necrosis factor-alpha, as well as the profibrogenic genes osteopontin, transforming growth factor-beta 1, visfatin, phosphatidylinositol 3-kinase, matrix metalloproteinase-2 (MMP-2) and MMP-9 was observed. WY14643 treatment restored expression of cytokines altered by ethanol plus CCl4 treatment and concomitantly ameliorated the liver injury.

CONCLUSIONS

The present study provides evidence for the protective role of PPARα induction in ameliorating ethanol mediated fibrosis through mediation of inflammatory and fibrogenic factors.

摘要

背景

过氧化物酶体增殖物激活受体α(PPARα)可改善乙醇诱导的肝脂肪变性。然而,其在酒精性肝纤维化中的作用尚未完全阐明。本研究旨在阐明 PPARα在乙醇诱导的小鼠肝纤维化中的作用及其分子机制。

方法

C57BL/6J 小鼠给予含 4%乙醇的 Lieber-DeCarli 液体饮食 8 周,最后 4 周腹腔注射 5%四氯化碳(CCl4)诱导酒精性肝纤维化。在最后几周给小鼠注射 PPARα激动剂 WY14643。评估 PPARα诱导对肝组织学、肝星状细胞(HSCs)活化以及肝内炎症和纤维化因子表达的影响。

结果

乙醇加 CCl4 处理的小鼠表现出进行性肝损伤,包括肝细胞碎片状坏死、严重的炎症细胞浸润和桥接纤维化。这伴随着肝内 PPARα和保护性细胞因子脂联素、血红素加氧酶-1 和白细胞介素-10 的表达下调。此外,促炎细胞因子肿瘤坏死因子-α以及促纤维化基因骨桥蛋白、转化生长因子-β1、内脏脂肪素、磷脂酰肌醇 3-激酶、基质金属蛋白酶-2(MMP-2)和 MMP-9 的表达上调。WY14643 治疗恢复了乙醇加 CCl4 处理改变的细胞因子表达,并同时改善了肝损伤。

结论

本研究为 PPARα诱导通过调节炎症和纤维化因子改善乙醇介导的纤维化提供了证据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aef7/3608939/4d620c556964/1476-511X-12-11-7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aef7/3608939/892ca8a158ad/1476-511X-12-11-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aef7/3608939/1e1ff3ee15f7/1476-511X-12-11-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aef7/3608939/56616e90e748/1476-511X-12-11-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aef7/3608939/dc5c04d1d1fa/1476-511X-12-11-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aef7/3608939/3dae5ebb5987/1476-511X-12-11-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aef7/3608939/702e2745b5d4/1476-511X-12-11-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aef7/3608939/4d620c556964/1476-511X-12-11-7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aef7/3608939/892ca8a158ad/1476-511X-12-11-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aef7/3608939/1e1ff3ee15f7/1476-511X-12-11-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aef7/3608939/56616e90e748/1476-511X-12-11-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aef7/3608939/dc5c04d1d1fa/1476-511X-12-11-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aef7/3608939/3dae5ebb5987/1476-511X-12-11-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aef7/3608939/702e2745b5d4/1476-511X-12-11-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aef7/3608939/4d620c556964/1476-511X-12-11-7.jpg

相似文献

1
Activation of peroxisome proliferator activated receptor alpha ameliorates ethanol mediated liver fibrosis in mice.过氧化物酶体增殖物激活受体α的激活可改善乙醇诱导的小鼠肝纤维化。
Lipids Health Dis. 2013 Feb 6;12:11. doi: 10.1186/1476-511X-12-11.
2
Activation of peroxisome proliferator activated receptor alpha ameliorates ethanol induced steatohepatitis in mice.过氧化物酶体增殖物激活受体 α 的激活可改善乙醇诱导的小鼠脂肪性肝炎。
Lipids Health Dis. 2011 Dec 30;10:246. doi: 10.1186/1476-511X-10-246.
3
Diethylcarbamazine attenuates the expression of pro-fibrogenic markers and hepatic stellate cells activation in carbon tetrachloride-induced liver fibrosis.二乙碳酰氨嗪可减轻四氯化碳诱导的肝纤维化中促纤维化标志物的表达和肝星状细胞的激活。
Inflammopharmacology. 2018 Apr;26(2):599-609. doi: 10.1007/s10787-017-0329-0. Epub 2017 Apr 13.
4
Thymosin β4 suppresses CCl -induced murine hepatic fibrosis by down-regulating transforming growth factor β receptor-II.胸腺素 β4 通过下调转化生长因子 β 受体-Ⅱ抑制 CCl4 诱导的小鼠肝纤维化。
J Gene Med. 2018 Sep;20(9):e3043. doi: 10.1002/jgm.3043. Epub 2018 Aug 15.
5
[Establishment of a complex alcoholic liver fibrosis mouse model and investigation of OPN and TGF-beta1 hepatic expression].[复合性酒精性肝纤维化小鼠模型的建立及骨桥蛋白和转化生长因子-β1肝脏表达的研究]
Zhonghua Gan Zang Bing Za Zhi. 2013 Mar;21(3):207-12.
6
Administration of the potent PPARalpha agonist, Wy-14,643, reverses nutritional fibrosis and steatohepatitis in mice.强效PPARα激动剂Wy-14,643的给药可逆转小鼠的营养性肝纤维化和脂肪性肝炎。
Hepatology. 2004 May;39(5):1286-96. doi: 10.1002/hep.20170.
7
Effects of elafibranor on liver fibrosis and gut barrier function in a mouse model of alcohol-associated liver disease.依发布罗尼对酒精相关性肝病小鼠模型中肝纤维化和肠道屏障功能的影响。
World J Gastroenterol. 2024 Jul 28;30(28):3428-3446. doi: 10.3748/wjg.v30.i28.3428.
8
Fuzheng Huayu recipe prevents nutritional fibrosing steatohepatitis in mice.扶正化瘀方防治营养性肝纤维化的实验研究
Lipids Health Dis. 2012 Mar 28;11:45. doi: 10.1186/1476-511X-11-45.
9
Potential relationship between hepatobiliary osteopontin and peroxisome proliferator-activated receptor alpha expression following ethanol-associated hepatic injury in vivo and in vitro.乙醇相关肝损伤体内外模型中肝胆骨桥蛋白与过氧化物酶体增殖物激活受体α表达之间的潜在关系
Toxicol Sci. 2008 Nov;106(1):290-9. doi: 10.1093/toxsci/kfn165. Epub 2008 Aug 14.
10
Sauchinone attenuates liver fibrosis and hepatic stellate cell activation through TGF-β/Smad signaling pathway.柳杉双黄酮通过TGF-β/Smad信号通路减轻肝纤维化和肝星状细胞活化。
Chem Biol Interact. 2014 Dec 5;224:58-67. doi: 10.1016/j.cbi.2014.10.005. Epub 2014 Oct 16.

引用本文的文献

1
Mediating Role of Lipid Accumulation Products (LAP) in the Association of WBC with MASLD: SWH 2021-2023.脂质蓄积产物(LAP)在白细胞与代谢相关脂肪性肝病(MASLD)关联中的中介作用:SWH 2021 - 2023
J Inflamm Res. 2025 Aug 11;18:10845-10854. doi: 10.2147/JIR.S539627. eCollection 2025.
2
Molecular Biological Mechanisms of Action of Chrysophanol in Hepatic Stellate Cells Activated by Hepatic B Virus X Based on Network Pharmacology.基于网络药理学探讨大黄酚对乙肝病毒X蛋白激活的肝星状细胞的分子生物学作用机制
Intervirology. 2024;67(1):119-135. doi: 10.1159/000542355. Epub 2024 Dec 6.
3
Genetic architecture and key regulatory genes of fatty acid composition in Gushi chicken breast muscle determined by GWAS and WGCNA.

本文引用的文献

1
Osteopontin is a novel downstream target of SOX9 with diagnostic implications for progression of liver fibrosis in humans.骨桥蛋白是 SOX9 的一个新的下游靶点,对人类肝纤维化进展具有诊断意义。
Hepatology. 2012 Sep;56(3):1108-16. doi: 10.1002/hep.25758.
2
Activation of peroxisome proliferator activated receptor alpha ameliorates ethanol induced steatohepatitis in mice.过氧化物酶体增殖物激活受体 α 的激活可改善乙醇诱导的小鼠脂肪性肝炎。
Lipids Health Dis. 2011 Dec 30;10:246. doi: 10.1186/1476-511X-10-246.
3
Osteopontin, an oxidant stress sensitive cytokine, up-regulates collagen-I via integrin α(V)β(3) engagement and PI3K/pAkt/NFκB signaling.
全基因组关联分析和加权基因共表达网络分析揭示了固始鸡胸肌脂肪酸组成的遗传结构和关键调控基因。
BMC Genomics. 2023 Aug 3;24(1):434. doi: 10.1186/s12864-023-09503-1.
4
Microbiome-Based Metabolic Therapeutic Approaches in Alcoholic Liver Disease.基于微生物组的代谢治疗方法在酒精性肝病中的应用。
Int J Mol Sci. 2022 Aug 6;23(15):8749. doi: 10.3390/ijms23158749.
5
Activation of PPARα-catalase pathway reverses alcoholic liver injury via upregulating NAD synthesis and accelerating alcohol clearance.过氧化物酶体增殖物激活受体α-过氧化氢酶通路通过上调 NAD 合成和加速酒精清除来逆转酒精性肝损伤。
Free Radic Biol Med. 2021 Oct;174:249-263. doi: 10.1016/j.freeradbiomed.2021.08.005. Epub 2021 Aug 11.
6
4-phenylbutyric acid promotes hepatocellular carcinoma via initiating cancer stem cells through activation of PPAR-α.4- 苯基丁酸通过激活 PPAR-α 启动癌干细胞促进肝癌。
Clin Transl Med. 2021 Apr;11(4):e379. doi: 10.1002/ctm2.379.
7
Naoxintong Retards Atherosclerosis by Inhibiting Foam Cell Formation Through Activating Pparα Pathway.脑心通通过激活过氧化物酶体增殖物激活受体α通路抑制泡沫细胞形成来延缓动脉粥样硬化。
Curr Mol Med. 2018;18(10):698-710. doi: 10.2174/1566524019666190207143207.
8
Resveratrol Protects Against Renal Damage via Attenuation of Inflammation and Oxidative Stress in High-Fat-Diet-Induced Obese Mice.白藜芦醇通过减轻高脂饮食诱导肥胖小鼠的炎症和氧化应激来保护肾脏免受损伤。
Inflammation. 2019 Jun;42(3):937-945. doi: 10.1007/s10753-018-0948-7.
9
Label‑free quantitative proteomics and bioinformatics analyses of alcoholic liver disease in a chronic and binge mouse model.慢性和 binge 型小鼠模型中酒精性肝病的无标记定量蛋白质组学和生物信息学分析。
Mol Med Rep. 2018 Aug;18(2):2079-2087. doi: 10.3892/mmr.2018.9225. Epub 2018 Jun 26.
10
The Active Components of Fuzheng Huayu Formula and Their Potential Mechanism of Action in Inhibiting the Hepatic Stellate Cells Viability - A Network Pharmacology and Transcriptomics Approach.扶正化瘀方的活性成分及其抑制肝星状细胞活力的潜在作用机制——基于网络药理学和转录组学的方法
Front Pharmacol. 2018 May 24;9:525. doi: 10.3389/fphar.2018.00525. eCollection 2018.
骨桥蛋白,一种氧化应激敏感细胞因子,通过整合素 α(V)β(3)的结合和 PI3K/pAkt/NFκB 信号通路上调胶原-I。
Hepatology. 2012 Feb;55(2):594-608. doi: 10.1002/hep.24701.
4
Matrix metalloprotease-9 induces transforming growth factor-β(1) production in airway epithelium via activation of epidermal growth factor receptors.基质金属蛋白酶-9 通过激活表皮生长因子受体诱导气道上皮细胞产生转化生长因子-β(1)。
Life Sci. 2011 Aug 1;89(5-6):204-12. doi: 10.1016/j.lfs.2011.06.008. Epub 2011 Jun 22.
5
The antifibrotic effects of TGF-β1 siRNA on hepatic fibrosis in rats.TGF-β1 siRNA 对大鼠肝纤维化的抗纤维化作用。
Biochem Biophys Res Commun. 2011 Jun 10;409(3):448-53. doi: 10.1016/j.bbrc.2011.05.023. Epub 2011 May 10.
6
A key role for Pre-B cell colony-enhancing factor in experimental hepatitis.Pre-B 细胞集落增强因子在实验性肝炎中的关键作用。
Hepatology. 2011 Aug;54(2):675-86. doi: 10.1002/hep.24416. Epub 2011 Jun 26.
7
Interleukin-10-mediated heme oxygenase 1-induced underlying mechanism in inflammatory down-regulation by norfloxacin in cirrhosis.诺氟沙星通过白细胞介素-10 介导体细胞血红素加氧酶 1 诱导的机制下调肝硬化炎症反应。
Hepatology. 2011 Mar;53(3):935-44. doi: 10.1002/hep.24102.
8
Induction of heme oxygenase-1 protects against nutritional fibrosing steatohepatitis in mice.诱导血红素加氧酶-1 可预防小鼠营养性纤维性脂肪性肝炎。
Lipids Health Dis. 2011 Feb 12;10:31. doi: 10.1186/1476-511X-10-31.
9
TGF-beta1-induced PI3K/Akt/NF-kappaB/MMP9 signalling pathway is activated in Philadelphia chromosome-positive chronic myeloid leukaemia hemangioblasts.TGF-β1 诱导的 PI3K/Akt/NF-κB/MMP9 信号通路在费城染色体阳性慢性髓性白血病血原性细胞中被激活。
J Biochem. 2011 Apr;149(4):405-14. doi: 10.1093/jb/mvr016. Epub 2011 Feb 1.
10
TGF-β1 as possible link between loss of bone mineral density and chronic inflammation.TGF-β1 可能是骨密度丧失和慢性炎症之间的联系。
PLoS One. 2010 Nov 22;5(11):e14073. doi: 10.1371/journal.pone.0014073.